SUV420H2 suppresses breast cancer cell invasion through down regulation of the SH2 domain-containing focal adhesion protein tensin-3

Experimental Cell Research

Volumn 334, Issue 1, 2015, Pages 90-99

  Shinchi, Yoshimi ^a   Hieda, Miki ^a   Nishioka, Yu ^a   Matsumoto, Ayaka ^a   Yokoyama, Yuhki ^a   Kimura, Hiroshi ^b,c   Matsuura, Shuji ^a   Matsuura, Nariaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Breast tumor; Cell invasion; Histone H4K20me3; SUV420H2; Tensin 3

Indexed keywords

DNA; HISTONE H4 LYSINE 20 TRIMETHYLATION; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 1BETA; INTERLEUKIN 24; MESSENGER RNA; METHYLTRANSFERASE; PLACENTA PROTEIN 5; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN; PROTEIN SH2; SERINE PROTEINASE INHIBITOR; SERPIN B3; SMALL INTERFERING RNA; SUPPRESSOR OF VARIEGATION 4-20 HOMOLOG 2; TENSIN; TENSIN 1; TENSIN 2; TENSIN 3; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; SUV420H2 PROTEIN, HUMAN; TENSINS;

ARTICLE; BREAST CANCER CELL LINE; CANCER GROWTH; CANCER REGRESSION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; NUCLEIC ACID AMPLIFICATION; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSCRIPTION INITIATION SITE; TUMOR INVASION; UPREGULATION; BREAST TUMOR; FEMALE; FOCAL ADHESION; GENETICS; METABOLISM; NEOPLASM INVASIVENESS; PATHOLOGY; SRC HOMOLOGY DOMAIN; TUMOR CELL CULTURE;

BREAST NEOPLASMS; DOWN-REGULATION; FEMALE; FOCAL ADHESIONS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; SRC HOMOLOGY DOMAINS; TUMOR CELLS, CULTURED;

EID: 84929288426     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.03.010     Document Type: Article

References (47)

1. Fraga M.F., Ballestar E., Villar-Garea A., Boix-Chornet M., Espada J., Schotta G., et al. Loss of acetylation at Lys16 and tri-methylation at Lys20 ofhistone H4 is a common hallmark of human cancer. Nat. Genet. 2005, 37:391-400.
2. Greer E.L., Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 2012, 13:343-357.
3. Van Den Broeck A., Brambilla E., Moro-Sibilot D., Lantuejoul S., Brambilla C., Eymin B., et al. Loss of histone H4K20 Trimethylation occurs in preneoplasia and influences prognisis of non-small cell lung cancer. Clin. Cancer Res. 2008, 14:7237-7245.
4. Elsheikh S.E., Green A.R., Rakha E.A., Powe D.G., Ahmed R.A., Collins H.M., et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 2009, 69:3802-3809.
5. Yokoyama Y., Matsumoto A., Hieda M., Shinchi Y., Ogihara E., Hamada M., et al. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity. Breast Cancer Res. 2014, 16:R66.
6. Seligson D.B., Horvath S., Shi T., Yu H., Tze S., Grunstein M., Kurdistani S.K. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005, 435:1262-1266.
7. Nishioka K., Rice J.C., Sarma K., Erdjument-Bromage H., Werner J., Wang Y., et al. PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. Mol. Cell 2002, 9:1201-1213.
8. Schotta G., Lachner M., Sarma K., Ebert A., Sengupta R., Reuter G., et al. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev. 2004, 18:1251-1262.
9. Schotta G., Sengupta R., Kubicek S., Malin S., Kauer M., Callén E., et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 2008, 22:2048-2061.
10. Benetti R., Gonzalo S., Jaco I., Schotta G., Klatt P., Jenuwein T., Blasco M.A. Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination. J. Cell Biol. 2007, 178:925-936.
11. Trydyak V.P., Kovalchuk O., Pogribny I.P. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, SUV420H2 histone methyltransferase and methyl-binding proteins. Cancer Biol. Ther. 2006, 5:65-70.
12. Pogribny I.P., Tryndyak V.P., Muskhelishvili L., Rusyn I., Ross S.A. Methyl deficiency, alterations in global histone modifications, and carcinogenesis. J. Nutr. 2007, 137:216S-222S.
13. Gonzalo S., García-Cao M., Fraga M.F., Schotta G., Peters A.H., Cotter S.E., et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nat. Cell Biol. 2005, 7:420-428.
14. Kourmouli N., Jeppesen P., Mahadevhaiah S., Burgoyne P., Wu R., Gilbert D.M., et al. Heterochromatin and tri-methylated lysine 20 of histone H4 in animals. J. Cell Sci. 2004, 117:2491-2501.
15. Jørgensen S., Schotta G., Sørensen C.S. Histon H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity. Nucleic Acids Res. 2013, 4:2797-2806.
16. Mikkelsen T.S., Ku M., Jaffe D.B., Issac B., Lieberman E., Giannoukos G., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560.
17. Congdon L.M., Houston S.I., Veerappan C.S., Spektor T.M., Rice J.C. PR-Set7-mediated monomethylation of histone H4 lysine 20 at specific genomic regions induces transcriptional repression. J. Cell. Biochem. 2010, 110:609-619.
18. Cui Y., Liao Y.C., Lo S.H. Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3. Mol. Cancer Res. 2004, 2:225-232.
19. Qian X., Li G., Vass W.C., Papageorge A., Walker R.C., Asnaghi L., et al. The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell 2009, 16:246-258.
20. Hayashi-Takanaka Y., Yamagata K., Wakayama T., et al. Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling. Nucleic Acids Res. 2011, 39:6475-6488.
21. Chandra T., Kirschner K., Thuret J.Y., Pope B.D., Ryba T., Newman S., Ahmed K., Samarajiwa S.A., Salama R., Carroll T., Stark R., et al. Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol. Cell 2012, 47:203-214.
22. Hieda M., Matsuura N., Kimura H. Histone modifications associated with cancer cell migration and invasion. Methods Mol. Biol. 2015, 1238:301-317.
23. Zhong Q., Zhong Q., Kowluru R.A. Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes 2011, 60:1304-1313.
24. Kapoor-Vazirani P., Kagey J.D., Vertino P.M. SUV420H2-mediated H4K20 trimethylation enforces RNA polymerase II promoter-proximal pausing by blocking hMOF-dependent H4K16 acetylation. Mol. Cell. Biol. 2011, 31:1594-1609.
25. Stender J.D., Pascual G., Liu W., Kaikkonen M.U., Do K., Spann N.J., et al. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol. Cell 2012, 48:28-38.
26. Nicetto D., Hahn M., Jung J., Schneider T.D., Straub T., David R., et al. Suv4-20h Histone methyltransferases promote neuroectodermal differentiation by silencing the pluripotency-associated Oct-25 gene. PLoS Genet. 2013, 9:e1003188.
27. Bauer K., Mierke C., Behrens J. Expression profiling reveals genes associated with transendothelial migration of tumor cells: a functional role for αVβ3 integrin. Int. J. Cancer 2007, 121:1910-1918.
28. Dombkowski A.A., Sultana Z., Craig D.B., Jamil H. In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis. Cancer Inform. 2011, 10:13-29.
29. Al-Rawi M.A., Rmali K., Watkins G., Mansel R.E., Jiang W.G. Aberrant expression of interleukin-7 (IL-7) and its signaling complex in human breast cancer. Eur. J. Cancer 2004, 40:494-502.
30. Ruzinova M.B., Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 2003, 13:410-418.
31. Ogino H., Yano S., Kakiuchi S., Muguruma H., Ikuta K., Hanibuchi M. Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice. Clin. Cancer Res. 2008, 14:660-667.
32. Smith P., Syed N., Crook T. Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3. Cell Cycle 2006, 5:1262-1264.
33. Kawakami K., Kawakami M., Snoy P.J., Husain S.R., Puri R.K. In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice. J. Exp. Med. 2001, 194:1743-1754.
34. Sauane M., Gopalkrishnan R.V., Sarkar D., Su Z.Z., Lebedeva I.V., et al. MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 2003, 14:35-51.
35. Croucher D., Saunders D.N., Lobov S., Ranson M. Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat. Rev. Cancer 2008, 8:535-545.
36. Guo H., Lin Y., Zhang H., Liu J., Zhang N., Li Y., et al. Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. BMC Mol. Biol. 2007, 8:110.
37. Xu J., Yin Z., Cao S., Gao W., Liu L., Yin Y., et al. Systematic review and meta-analysis on the association between IL-1B polymorphisms and cancer risk. PLoS One 2013, 8:e63654. 10.1371/journal.pone.0063654.
38. Brown J.R., DuBois R.N. COX-2: a molecular target for colorectal cancer prevention. J. Clin. Oncol. 2005, 23:2840-2855.
39. Lo S.H., Lo T.B. Cten, a COOH-terminal tensin-like protein with prostate restricted expression, is down-regulated in prostate cancer. Cancer Res. 2002, 62:4217-4221.
40. Lo S.H. Tensin. Int. J. Biochem. Cell Biol. 2004, 36:31-34.
41. Gerlitz G., Livnat I., Ziv C., Yarden O., Bustin M., Reiner O. Migration cues induce chromatin alterations. Traffic 2007, 8:1521-1529.
42. Gerlitz G., Bustin M. Efficient cell migration requires global chromatin condensation. J. Cell Sci. 2010, 123:2207-2217.
43. Gerlitz G., Bustin M. The role of chromatin structure in cell migration. Trends Cell Biol. 2011, 21:6-11.
44. Morini M., Mottolese M., Ferrari N., Ghiorzo F., Buglioni S., Mortarini R. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 2000, 87:336-342.
45. Lindberg U., Karlsson R., Lassing I., Schutt C.E., Höglund A.S. The microfilament system and malignancy. Semin. Cancer Biol. 2008, 18:2-11.
46. Kim A., Kiefer C.M., Dean A. Distinctive signatures of histone methylation in transcribed coding and noncoding human beta-globin sequences. Mol. Cell. Biol. 2007, 27:1271-1279.
47. Vakoc C.R., Sachdeva M.M., Wang H., Blobel G.A. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell. Biol. 2006, 26:9185-9195.